A new issue brief estimates potential coronavirus treatment costs to large employer health plans and their enrollees by looking at typical spending for hospital admissions for pneumonia. The analysis finds that, for pneumonia admissions with major comp…
In this post for The JAMA Forum, Larry Levitt examines both the Democratic candidates’ proposals and the Trump administration’s record on lowering drug prices, which remains a top issue for the public with bi-partisan support.
This data note captures February 2020 poll findings on the public’s worries about and experiences with unexpected and surprise medical bills.
When it comes to family budget concerns, unexpected medical bills top Americans’ list of worries, with two-thirds (65%) of the public saying they are at least somewhat worried, including 35% who say they are “very” worried, the latest KFF Health Tracki…
This quick primer explains where the 7 Democratic candidates for president participating in the Feb. 25 debate in South Carolina stand on health reform.
This quick primer explains where the 7 Democratic candidates for president participating in the Feb. 25 debate in South Carolina stand on health reform.
This quick primer explains where the 7 Democratic candidates for president participating in the Feb. 25 debate in South Carolina stand on health reform.
With lowering prescription drug costs a top priority for Americans, the Trump Administration, presidential candidates, members of Congress, and several states are proposing to allow the importation of drugs from abroad, chiefly Canada. The idea of allo…
These FAQs discuss recent efforts related to prescription drug importation, the history of this approach, challenges that previous efforts to carry out importation proposals have faced, and stakeholder views.
This infographic examines public opinion on surprise medical billing in the United States as part of the Visualizing Health Policy infographic series, produced in partnership with the Journal of the American Medical Association (JAMA).
